Home Cart 0 Sign in  
X

[ CAS No. 909036-46-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 909036-46-0
Chemical Structure| 909036-46-0
Chemical Structure| 909036-46-0
Structure of 909036-46-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 909036-46-0 ]

Related Doc. of [ 909036-46-0 ]

Alternatived Products of [ 909036-46-0 ]

Product Details of [ 909036-46-0 ]

CAS No. :909036-46-0 MDL No. :MFCD09763660
Formula : C5H4ClIN2 Boiling Point : -
Linear Structure Formula :- InChI Key :BYVMKCHHWASQFN-UHFFFAOYSA-N
M.W : 254.46 Pubchem ID :24229208
Synonyms :

Calculated chemistry of [ 909036-46-0 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.37
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.49
Log Po/w (XLOGP3) : 1.78
Log Po/w (WLOGP) : 1.93
Log Po/w (MLOGP) : 1.36
Log Po/w (SILICOS-IT) : 2.32
Consensus Log Po/w : 1.78

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.03
Solubility : 0.236 mg/ml ; 0.000928 mol/l
Class : Soluble
Log S (Ali) : -2.22
Solubility : 1.55 mg/ml ; 0.00609 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.24
Solubility : 0.148 mg/ml ; 0.000581 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.04

Safety of [ 909036-46-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 909036-46-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 909036-46-0 ]
  • Downstream synthetic route of [ 909036-46-0 ]

[ 909036-46-0 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 14432-12-3 ]
  • [ 800402-12-4 ]
  • [ 909036-46-0 ]
YieldReaction ConditionsOperation in experiment
41% With sodium acetate; Iodine monochloride In acetic acid at 70℃; for 3.5 h; 4-Amino-2-chloro-5-iodopyridine (11); [00197] 4-Amino-2-chloropyridine (3.20 g 25 mmole) was stirred in acetic acid (20 mL) with sodium acetate (4.1 g 50 mmol) To the mixture was added a solution of iodine monochloride (4.1 g 25 mmol) in acetic acid (10 mL) and the reaction was heated at 70 °C for 3.5 h. Most of the acetic acid was evaporated and the reaction diluted with water (200 mL). The products were extracted with ethyl acetate (80, 70, 70 mL). The combined extracts were washed with 10percent sodium carbonate solution (100 mL), with 5percent sodium thiosulfate solution and with brine; then dried and evaporated. The crude product was purified by flash column chromatography on silica; eluting with 5percent ethyl acetate in dichloromethane, with 10percent ethyl acetate in dichloromethane and with 20percent ethyl acetate in dichloromethane to give first a small amount of di-iodinated product (618mg, 6.5percent); then the desired product 4-amino-5-iodo-2-chloropyridine (11 ) (2.64 g, 41 percent) and then the isomeric 4-amino-2-chloro-3-iodopyridine (12) (2.61 g, 41 percent). 4-Amino-5-iodo-2- chloropyridine (11 ) : 1 H-NMR (500 MHz, DMSO-d6): 6.48 (br s, 2H), 6.63 (s, 1 H), 8.19 (s, 1 H). 4-Amino-2-chloro-3-iodopyridine (12): 1 H-NMR (500MHz, DMSO-d6): 6.50 (br s, 2H), 6.54 (d, J= 5.36 Hz, 1 H); 7.74 (d, J= 5.68 Hz, 1 H).
41% at 70℃; for 3.5 h; 4-Amino-2-chloro-5-iodopyridine (11)
4-Amino-2-chloropyridine (3.20 g 25 mmole) was stirred in acetic acid (20 mL) with sodium acetate (4.1 g 50 mmol) To the mixture was added a solution of iodine monochloride (4.1 g 25 mmol) in acetic acid (10 mL) and the reaction was heated at 70° C. for 3.5 h.
Most of the acetic acid was evaporated and the reaction diluted with water (200 mL).
The products were extracted with ethyl acetate (80, 70, 70 mL).
The combined extracts were washed with 10percent sodium carbonate solution (100 mL), with 5percent sodium thiosulfate solution and with brine; then dried and evaporated. The crude product was purified by flash column chromatography on silica; eluting with 5percent ethyl acetate in dichloromethane, with 10percent ethyl acetate in dichloromethane and with 20percent ethyl acetate in dichloromethane to give first a small amount of di-iodinated product (618 mg, 6.5percent); then the desired product 4-amino-5-iodo-2-chloropyridine (11) (2.64 g, 41percent) and then the isomeric 4-amino-2-chloro-3-iodopyridine (12) (2.61 g, 41percent). 4-Amino-5-iodo-2-chloropyridine (11): 1H-NMR (500 MHz, DMSO-d6): 6.48 (br s, 2H), 6.63 (s, 1H), 8.19 (s, 1H). 4-Amino-2-chloro-3-iodopyridine (12): 1H-NMR (500 MHz, DMSO-d6): 6.50 (br s, 2H), 6.54 (d, J=5.36 Hz, 1H); 7.74 (d, J=5.68 Hz, 1H).
39% With N-iodo-succinimide In N,N-dimethyl-formamide at 80℃; for 3 h; Intermediate 252A: 2-chloro-5-iodopyridin-4-amine To a stirred solution of 2-chloropyridin-4-amine (5 g, 39 mmol) in DMF (50 mL) was added NIS (8.75 g, 39 mmol). The reaction mixture was then heated at 80 °C for 3 h. The mixture was cooled and the DMF removed in vacuo. The residue was partitioned between EtOAc and water and the layers were separated. The organic layer was dried over Na2S04, filtered, and concentrated. The product was purified via column chromatography (10percent EtO Ac/pet ether) to afford 2-chloro-5-iodopyridin-4-amine (4 g, 39percent yield). LCMS: 254.8 (M+). Further elution with 12percent EtO Ac/pet ether afforded 2- chloro-3-iodopyridin-4-amine (4 g, 39percent yield).
11.6 g at 80℃; for 3 h; 2-Chloro-4-aminopyridine (25 g, 194 mmol)And potassium acetate (19. 05 g, 194 mmol) were dissolved in 250 mL acetic acid and heated to 80 ° C. A solution of (31.56 g, 194 mmol) in acetic acid (40 mL) was added dropwise and the reaction mixture was stirred at 80 C for 3 h. The reaction mixture was cooled to room temperature and neutralized with saturated aqueous NaHC03 solution. A dark, off-white solid precipitated, which was dissolved in dichloromethane and washed with saturated aqueous NaHSO3, dried over Na2S04, concentrated and purified by column chromatography using hexane and ethyl acetate as eluents. 1. 6 g of the title compound were isolated,Along with 13. 4 g of the non-targeted isomer.

Reference: [1] Patent: WO2012/123745, 2012, A1, . Location in patent: Page/Page column 67-68
[2] Patent: US2013/345181, 2013, A1, . Location in patent: Page/Page column 0625; 0631
[3] Patent: WO2016/210034, 2016, A1, . Location in patent: Page/Page column 171-172
[4] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 17, p. 4567 - 4570
[5] Patent: CN102449107, 2016, B, . Location in patent: Paragraph 0318; 0319; 0320
  • 2
  • [ 14432-12-3 ]
  • [ 800402-12-4 ]
  • [ 909036-46-0 ]
  • [ 1171919-00-8 ]
YieldReaction ConditionsOperation in experiment
49.7% With potassium acetate; Iodine monochloride In acetic acid at 70℃; for 4 h; Inert atmosphere A mixture of 2-chloro-4-amino pyridine 1 (20g, 0.15mol), potassium acetate (22.9g, 0.23mol) and ICl (27.7g, 0.17mol) in glacial acetic acid (200mL) was heated to 70°C for 4h. The solvent was concentrated under reduced pressure. The residue was neutralized with 10percent NaHCO3 solution (250mL) and extracted with two 300-mL portions of EtOAc. The combined organic extracts were washed with brine (200mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuum. The crude product showed a mixture of iodopyridines 2, 3 and 4 in the ratio 45:45:10. The required compound 2 (elution 2) was isolated via normal phase preparative HPLC (mobile phase: 60:40, 0.1percent TFA in hexane-IPA; column: SunFire Silica 19*150mm, 5μm; Flow rate: 18.0mL/min) in 49.7percent yield (19.7g) as an off white solid.
49.7% at 70℃; for 4 h; Inert atmosphere A mixture of 2-chloro-4-amino pyridine 1 (20g, 0.15mol), potassium acetate (22.9g, 0.23mol) and ICl (27.7g, 0.17mol) in glacial acetic acid (200mL) was heated to 70°C for 4h. After completion of the reaction, the solvent was concentrated under reduced pressure. The residue was neutralized with 10percent NaHCO3 solution (250mL) and extracted with two 300-mL portions of EtOAc. The combined organic extracts were washed with brine (200mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuum. The crude product showed a mixture of iodopyridines 2, 3 and 4 in the ratio 45:45:10. The required compound 2 (elution 3) was isolated via normal phase preparative HPLC (mobile phase: 60:40, 0.1percent TFA in hexane-IPA; column: SunFire Silica 19×150mm, 5μm; Flow rate: 18.0mL/min) in 49.7percent yield (19.7g) as an off white solid; mp 102.9–104.1°C; 1H NMR (400MHz, DMSO-D6): δ 7.73 (d, J=4.0Hz, 1H), 6.52 (d, J=4.0Hz, 1H), 6.50 (s, 2H); MS (m/z): 255.0 [M+H]+. Anal. calcd. for C5H4ClIN2: C, 23.60; H, 1.58; N, 11.01; found: C, 23.59; H, 1.578; N, 10.99
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 77, p. 288 - 297
[2] Journal of Molecular Structure, 2014, vol. 1081, p. 85 - 95
[3] Journal of Organic Chemistry, 2012, vol. 77, # 11, p. 5006 - 5016
[4] European Journal of Medicinal Chemistry, 2017, vol. 131, p. 275 - 288
  • 3
  • [ 14432-12-3 ]
  • [ 909036-46-0 ]
YieldReaction ConditionsOperation in experiment
45% at 70℃; for 16 h; Inert atmosphere A 50 mL single necked round bottom flask equipped with a magnetic stirrer bar,reflux condenser and nitrogen line was charged with 2-chloropyridin-4-amine 12 (2.50 g, 19.4 mmol, 1.0 equiv), sodiumacetate trihydrate (3.97 g, 29.2 mmol, 1.5 equiv), iodine monochloride(3.47 g, 21.4 mmol, 1.1 equiv) and glacial acetic acid(13.0 mL) and heated at 70 °C with magnetically facilitated stirring under nitrogen for 16 h, at which point tlc and GC/MS (EI) analysisshowed that the starting material had been consumed. The reactionmixture was cooled and transferred to a separating funnel where itwas carefully quenched with portion wise addition of solidpowdered sodium hydrogencarbonate (32.3 g), water (75 mL) and ethyl acetate (75 mL). The resultant effervescence was allowed to subside and the mixture was not shaken. The layers were thenseparated and the aqueous layer was extracted with ethyl acetate(6 x 25 mL), with shaking. The organic layers were combined anddried over magnesium sulfate and the solvent was removed viarotary evaporation. The residue was purified by portionwise flashcolumn chromatography over silica using n-hexane/ethyl acetate(94:6 to 60:40) mixtures as eluent to give 2-chloro-3-iodopyridin-4-amine 13 as a light brown solid (2.21 g, 45percent), a sample of whichhad 1H NMR spectral data and low resolution GC/MS (EI) massspectral data identical to those in the literature [12].
42% With N-iodo-succinimide In N,N-dimethyl-formamide at 20 - 55℃; 2-Chloro-4-aminopyridine (1.8 g, 14 mmol) was dissolved in 28 ml dimethylformamide. N-lodosuccinimide (3.15 g, 14 mmol) was added and the mixture was stirred at room temperature overnight.
Additional N-iodosuccinimide (3.15 g, 14 mmol) was added and the mixture wasa stirred at 55ºC overnight.
The mixture was evaporated to dryness and the residue was partitioned between ethyl acetate and water.
The aqueous was extracted with ethyl acetate and the combined organics were dried over sodium sulphate, filtered and evaporated.
Purification by flash chromatography (ethyl acetate-hexane gradient, 15:85 rising to 25:75) gave 1.5 g (5.9 mmol, 42percent) of the title compound as a purple solid.
1H NMR (300 MHz, CHLOROFORM-d) δ ppm 8.34 (1 H, s), 6.63 (1 H, s), 4.75 (2 H, br. s.).
42% With N-iodo-succinimide In N,N-dimethyl-formamide at 20 - 55℃; PREPARATION 41 2-Chloro-3-iodopyridin-4-amine 2-Chloro-4-aminopyridine (1 .8 g, 14 mmol) was dissolved in 28 ml dimethylformamide. N-lodosuccinimide (3.15 g, 14 mmol) was added and the mixture was stirred at room temperature overnight. Additional N-iodosuccinimide (3.15 g, 14 mmol) was added and the mixture wasa stirred at 55 °C overnight. The mixture was evaporated to dryness and the residue was partitioned between ethyl acetate and water. The aqueous was extracted with ethyl acetate and the combined organics were dried over sodium sulphate, filtered and evaporated under reduced pressure. Purification by flash chromatography (ethyl acetate-hexane gradient, 15:85 rising to 25:75) gave 1 .5 g (5.9 mmol, 42percent) of the title compound as a purple solid. 1 H N MR (300 MHz, CHLOROFORM-d) δ ppm 8.34 (1 H, s), 6.63 (1 H, s), 4.75 (2 H, br. s.).
42% With N-iodo-succinimide In N,N-dimethyl-formamide at 20 - 55℃; 2-Chloro-4-aminopyridine (1.8 g, 14 mmol) was dissolved in 28 ml   dimethylformamide. N-Iodosuccinimide (3.15 g, 14 mmol) was added and the mixture was stirred at room temperature overnight. Additional   N-iodosuccinimide (3.15 g, 14 mmol) was added and the mixture wasa stirred at 55 ºC overnight. The mixture was evaporated to dryness and the residue was partitioned between ethyl acetate and water. The aqueous was extracted with ethyl acetate and the combined organics were dried over sodium sulphate, filtered and evaporated under reduced pressure. Purification by flash chromatography (ethyl acetate-hexane gradient, 15:85 rising to 25:75) gave 1.5 g (5.9 mmol, 42percent) of the   title compound as a purple solid. [0369] 1H NMR (300 MHz, CHLOROFORM-d) δ ppm 8.34 (1 H, s), 6.63 (1 H, s), 4.75 (2 H, br. s.).
41% at 70℃; 2-Chloro-pyridin-4-ylamine 1a* (3.2 g, 25 mmol) and sodium acetate (4.1 g, 50 mmol) were stirred in acetic acid (20 mL). A solution of iodine monochloride (4.1 g, 25 mmol) in acetic acid (10 mL) was added and the reaction mixture was heated to 70 °C for approximately three h (NB: reaction mixture became a solution at -50 °C, the brown colour faded and a precipitate formed as the reaction proceeded). The reaction mixture was cooled to room temperature, then poured onto water (700 mL), and extracted with AcOEt (2 χ 750 mL). The organic phase was carefully washed with a saturated aqueous solution of sodium carbonate (500 mL) followed by a 10percent solution of sodium thiosulfate (500 mL), dried over MgSO4 and concentrated in vacuo. The crude product was purified by column chromatography using 10percent AcOEt in DCM to yield 2-chloro-3-iodo-pyridin-4-ylamine 2a* (2.6 g, 41 percent). NMR (400 MHz, CDCl3) δ (ppm): 7.88 (1 H, d, J = 5.5 Hz), 6.46 (1 H, d, J = 5.5 Hz), 4.96 (2 H, s).
41% With sodium acetate; Iodine monochloride In acetic acid at 70℃; for 3 h; 10.3
Synthesis of 2-chloro-3-iodo-pyridin-4-ylamine 2a*
2-Chloro-pyridin-4-ylamine 1a* (3.2 g, 25 mmol) and sodium acetate (4.1 g, 50 mmol) were stirred in acetic acid (20 mL).
A solution of iodine monochloride (4.1 g, 25 mmol) in acetic acid (10 mL) was added and the reaction mixture was heated to 70 °C for approximately three h (NB: reaction mixture became a solution at ∼50 °C, the brown colour faded and a precipitate formed as the reaction proceeded).
The reaction mixture was cooled to room temperature, then poured onto water (700 mL), and extracted with AcOEt (2 x 750 mL).
The organic phase was carefully washed with a saturated aqueous solution of sodium carbonate (500 mL) followed by a 10percent solution of sodium thiosulfate (500 mL), dried over MgSO4 and concentrated in vacuo.
The crude product was purified by column chromatography using 10percent AcOEt in DCM to yield 2-chloro-3-iodo-pyridin-4-ylamine 2a* (2.6 g, 41 percent).
1H NMR (400 MHz, CDCl3) δ (ppm): 7.88 (1 H, d, J = 5.5 Hz), 6.46 (1 H, d, J = 5.5 Hz), 4.96 (2 H, s).

Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 128, p. 202 - 212
[2] Patent: EP2526945, 2012, A1, . Location in patent: Page/Page column 63
[3] Patent: WO2013/10880, 2013, A1, . Location in patent: Page/Page column 94
[4] Patent: EP2548876, 2013, A1, . Location in patent: Paragraph 0368; 0369
[5] Patent: WO2014/207260, 2014, A1, . Location in patent: Page/Page column 78
[6] Patent: EP2818472, 2014, A1, . Location in patent: Paragraph 0091
[7] Patent: WO2006/114180, 2006, A1, . Location in patent: Page/Page column 81-82
  • 4
  • [ 14432-12-3 ]
  • [ 800402-12-4 ]
  • [ 909036-46-0 ]
YieldReaction ConditionsOperation in experiment
41% With sodium acetate; Iodine monochloride In acetic acid at 70℃; for 3.5 h; 4-Amino-2-chloro-5-iodopyridine (11); [00197] 4-Amino-2-chloropyridine (3.20 g 25 mmole) was stirred in acetic acid (20 mL) with sodium acetate (4.1 g 50 mmol) To the mixture was added a solution of iodine monochloride (4.1 g 25 mmol) in acetic acid (10 mL) and the reaction was heated at 70 °C for 3.5 h. Most of the acetic acid was evaporated and the reaction diluted with water (200 mL). The products were extracted with ethyl acetate (80, 70, 70 mL). The combined extracts were washed with 10percent sodium carbonate solution (100 mL), with 5percent sodium thiosulfate solution and with brine; then dried and evaporated. The crude product was purified by flash column chromatography on silica; eluting with 5percent ethyl acetate in dichloromethane, with 10percent ethyl acetate in dichloromethane and with 20percent ethyl acetate in dichloromethane to give first a small amount of di-iodinated product (618mg, 6.5percent); then the desired product 4-amino-5-iodo-2-chloropyridine (11 ) (2.64 g, 41 percent) and then the isomeric 4-amino-2-chloro-3-iodopyridine (12) (2.61 g, 41 percent). 4-Amino-5-iodo-2- chloropyridine (11 ) : 1 H-NMR (500 MHz, DMSO-d6): 6.48 (br s, 2H), 6.63 (s, 1 H), 8.19 (s, 1 H). 4-Amino-2-chloro-3-iodopyridine (12): 1 H-NMR (500MHz, DMSO-d6): 6.50 (br s, 2H), 6.54 (d, J= 5.36 Hz, 1 H); 7.74 (d, J= 5.68 Hz, 1 H).
41% at 70℃; for 3.5 h; 4-Amino-2-chloro-5-iodopyridine (11)
4-Amino-2-chloropyridine (3.20 g 25 mmole) was stirred in acetic acid (20 mL) with sodium acetate (4.1 g 50 mmol) To the mixture was added a solution of iodine monochloride (4.1 g 25 mmol) in acetic acid (10 mL) and the reaction was heated at 70° C. for 3.5 h.
Most of the acetic acid was evaporated and the reaction diluted with water (200 mL).
The products were extracted with ethyl acetate (80, 70, 70 mL).
The combined extracts were washed with 10percent sodium carbonate solution (100 mL), with 5percent sodium thiosulfate solution and with brine; then dried and evaporated. The crude product was purified by flash column chromatography on silica; eluting with 5percent ethyl acetate in dichloromethane, with 10percent ethyl acetate in dichloromethane and with 20percent ethyl acetate in dichloromethane to give first a small amount of di-iodinated product (618 mg, 6.5percent); then the desired product 4-amino-5-iodo-2-chloropyridine (11) (2.64 g, 41percent) and then the isomeric 4-amino-2-chloro-3-iodopyridine (12) (2.61 g, 41percent). 4-Amino-5-iodo-2-chloropyridine (11): 1H-NMR (500 MHz, DMSO-d6): 6.48 (br s, 2H), 6.63 (s, 1H), 8.19 (s, 1H). 4-Amino-2-chloro-3-iodopyridine (12): 1H-NMR (500 MHz, DMSO-d6): 6.50 (br s, 2H), 6.54 (d, J=5.36 Hz, 1H); 7.74 (d, J=5.68 Hz, 1H).
39% With N-iodo-succinimide In N,N-dimethyl-formamide at 80℃; for 3 h; Intermediate 252A: 2-chloro-5-iodopyridin-4-amine To a stirred solution of 2-chloropyridin-4-amine (5 g, 39 mmol) in DMF (50 mL) was added NIS (8.75 g, 39 mmol). The reaction mixture was then heated at 80 °C for 3 h. The mixture was cooled and the DMF removed in vacuo. The residue was partitioned between EtOAc and water and the layers were separated. The organic layer was dried over Na2S04, filtered, and concentrated. The product was purified via column chromatography (10percent EtO Ac/pet ether) to afford 2-chloro-5-iodopyridin-4-amine (4 g, 39percent yield). LCMS: 254.8 (M+). Further elution with 12percent EtO Ac/pet ether afforded 2- chloro-3-iodopyridin-4-amine (4 g, 39percent yield).
11.6 g at 80℃; for 3 h; 2-Chloro-4-aminopyridine (25 g, 194 mmol)And potassium acetate (19. 05 g, 194 mmol) were dissolved in 250 mL acetic acid and heated to 80 ° C. A solution of (31.56 g, 194 mmol) in acetic acid (40 mL) was added dropwise and the reaction mixture was stirred at 80 C for 3 h. The reaction mixture was cooled to room temperature and neutralized with saturated aqueous NaHC03 solution. A dark, off-white solid precipitated, which was dissolved in dichloromethane and washed with saturated aqueous NaHSO3, dried over Na2S04, concentrated and purified by column chromatography using hexane and ethyl acetate as eluents. 1. 6 g of the title compound were isolated,Along with 13. 4 g of the non-targeted isomer.

Reference: [1] Patent: WO2012/123745, 2012, A1, . Location in patent: Page/Page column 67-68
[2] Patent: US2013/345181, 2013, A1, . Location in patent: Page/Page column 0625; 0631
[3] Patent: WO2016/210034, 2016, A1, . Location in patent: Page/Page column 171-172
[4] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 17, p. 4567 - 4570
[5] Patent: CN102449107, 2016, B, . Location in patent: Paragraph 0318; 0319; 0320
  • 5
  • [ 14432-12-3 ]
  • [ 800402-12-4 ]
  • [ 909036-46-0 ]
  • [ 1171919-00-8 ]
YieldReaction ConditionsOperation in experiment
49.7% With potassium acetate; Iodine monochloride In acetic acid at 70℃; for 4 h; Inert atmosphere A mixture of 2-chloro-4-amino pyridine 1 (20g, 0.15mol), potassium acetate (22.9g, 0.23mol) and ICl (27.7g, 0.17mol) in glacial acetic acid (200mL) was heated to 70°C for 4h. The solvent was concentrated under reduced pressure. The residue was neutralized with 10percent NaHCO3 solution (250mL) and extracted with two 300-mL portions of EtOAc. The combined organic extracts were washed with brine (200mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuum. The crude product showed a mixture of iodopyridines 2, 3 and 4 in the ratio 45:45:10. The required compound 2 (elution 2) was isolated via normal phase preparative HPLC (mobile phase: 60:40, 0.1percent TFA in hexane-IPA; column: SunFire Silica 19*150mm, 5μm; Flow rate: 18.0mL/min) in 49.7percent yield (19.7g) as an off white solid.
49.7% at 70℃; for 4 h; Inert atmosphere A mixture of 2-chloro-4-amino pyridine 1 (20g, 0.15mol), potassium acetate (22.9g, 0.23mol) and ICl (27.7g, 0.17mol) in glacial acetic acid (200mL) was heated to 70°C for 4h. After completion of the reaction, the solvent was concentrated under reduced pressure. The residue was neutralized with 10percent NaHCO3 solution (250mL) and extracted with two 300-mL portions of EtOAc. The combined organic extracts were washed with brine (200mL) and dried over anhydrous Na2SO4. The solvent was removed in vacuum. The crude product showed a mixture of iodopyridines 2, 3 and 4 in the ratio 45:45:10. The required compound 2 (elution 3) was isolated via normal phase preparative HPLC (mobile phase: 60:40, 0.1percent TFA in hexane-IPA; column: SunFire Silica 19×150mm, 5μm; Flow rate: 18.0mL/min) in 49.7percent yield (19.7g) as an off white solid; mp 102.9–104.1°C; 1H NMR (400MHz, DMSO-D6): δ 7.73 (d, J=4.0Hz, 1H), 6.52 (d, J=4.0Hz, 1H), 6.50 (s, 2H); MS (m/z): 255.0 [M+H]+. Anal. calcd. for C5H4ClIN2: C, 23.60; H, 1.58; N, 11.01; found: C, 23.59; H, 1.578; N, 10.99
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 77, p. 288 - 297
[2] Journal of Molecular Structure, 2014, vol. 1081, p. 85 - 95
[3] Journal of Organic Chemistry, 2012, vol. 77, # 11, p. 5006 - 5016
[4] European Journal of Medicinal Chemistry, 2017, vol. 131, p. 275 - 288
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 909036-46-0 ]

Chlorides

Chemical Structure| 856169-60-3

[ 856169-60-3 ]

2-Chloro-3,5-diiodopyridine

Similarity: 0.79

Chemical Structure| 343781-36-2

[ 343781-36-2 ]

2,4-Dichloro-3-iodopyridine

Similarity: 0.77

Chemical Structure| 800402-12-4

[ 800402-12-4 ]

2-Chloro-5-iodo-4-pyridinamine

Similarity: 0.75

Chemical Structure| 942206-23-7

[ 942206-23-7 ]

2,5-Dichloro-3-iodopyridine

Similarity: 0.75

Chemical Structure| 83410-15-5

[ 83410-15-5 ]

4-Chloro-5-iodo-6-methylpyrimidine

Similarity: 0.73

Amines

Chemical Structure| 88511-27-7

[ 88511-27-7 ]

4-Amino-3-iodopyridine

Similarity: 0.75

Chemical Structure| 800402-12-4

[ 800402-12-4 ]

2-Chloro-5-iodo-4-pyridinamine

Similarity: 0.75

Chemical Structure| 98136-86-8

[ 98136-86-8 ]

4-Amino-3,5-diiodopyridine

Similarity: 0.66

Chemical Structure| 79055-63-3

[ 79055-63-3 ]

2-Chloro-6-methylpyridin-4-amine

Similarity: 0.66

Chemical Structure| 426463-09-4

[ 426463-09-4 ]

2-Chloro-5-iodopyridin-3-amine

Similarity: 0.66

Related Parent Nucleus of
[ 909036-46-0 ]

Pyridines

Chemical Structure| 856169-60-3

[ 856169-60-3 ]

2-Chloro-3,5-diiodopyridine

Similarity: 0.79

Chemical Structure| 343781-36-2

[ 343781-36-2 ]

2,4-Dichloro-3-iodopyridine

Similarity: 0.77

Chemical Structure| 88511-27-7

[ 88511-27-7 ]

4-Amino-3-iodopyridine

Similarity: 0.75

Chemical Structure| 800402-12-4

[ 800402-12-4 ]

2-Chloro-5-iodo-4-pyridinamine

Similarity: 0.75

Chemical Structure| 942206-23-7

[ 942206-23-7 ]

2,5-Dichloro-3-iodopyridine

Similarity: 0.75